These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34604089)

  • 1. A Novel Seven Gene Signature-Based Prognostic Model to Predict Distant Metastasis of Lymph Node-Negative Triple-Negative Breast Cancer.
    Peng W; Lin C; Jing S; Su G; Jin X; Di G; Shao Z
    Front Oncol; 2021; 11():746763. PubMed ID: 34604089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and Validation of a Prognostic Risk Model for Triple-Negative Breast Cancer Based on Autophagy-Related Genes.
    Yan C; Liu Q; Jia R
    Front Oncol; 2022; 12():829045. PubMed ID: 35186763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative 3' Untranslated Region-Based Model to Identify Patients with Low Risk of Axillary Lymph Node Metastasis in Operable Triple-Negative Breast Cancer.
    Wang L; Hu X; Wang P; Shao ZM
    Oncologist; 2019 Jan; 24(1):22-30. PubMed ID: 30082491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prognostic model of triple-negative breast cancer based on miR-27b-3p and node status.
    Shen S; Sun Q; Liang Z; Cui X; Ren X; Chen H; Zhang X; Zhou Y
    PLoS One; 2014; 9(6):e100664. PubMed ID: 24945253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
    Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X
    Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and verification of a nomogram to predict tumor-specific mortality risk in triple-negative breast cancer: a competing risk model based on the SEER cohort study.
    Li Z; Shi Y; Wu L; Zhang H; Xue J; Li W; Wang X; Zhang L; Wang Q; Duo L; Wang M; Wang G
    Gland Surg; 2022 Dec; 11(12):1961-1975. PubMed ID: 36654948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An iron metabolism and immune related gene signature for the prediction of clinical outcome and molecular characteristics of triple-negative breast cancer.
    Li XF; Fu WF; Zhang J; Song CG
    BMC Cancer; 2022 Jun; 22(1):619. PubMed ID: 35668369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of an immune-related genes nomogram for the preoperative prediction of axillary lymph node metastasis in triple-negative breast cancer.
    Tan W; Xie X; Huang Z; Chen L; Tang W; Zhu R; Ye X; Zhang X; Pan L; Gao J; Tang H; Zheng W
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):288-297. PubMed ID: 31858816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and validation of a macrophage polarization-related prognostic index to predict the overall survival in patients with early-stage triple-negative breast cancer.
    Luo H; Hong R; Xu Y; Zheng Q; Xia W; Lu Q; Jiang K; Xu F; Chen M; Shi D; Deng W; Wang S
    Gland Surg; 2023 Feb; 12(2):225-242. PubMed ID: 36915811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Validation of a Novel Glycolysis-Related Gene Signature for Predicting the Prognosis and Therapeutic Response in Triple-Negative Breast Cancer.
    Zheng J; Zhang YF; Han GH; Fan MY; Du MH; Zhang GC; Zhang B; Qiao J; Zhang SX; Cao JM
    Adv Ther; 2023 Jan; 40(1):310-330. PubMed ID: 36316558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Risk Stratification Model for Predicting Overall Survival and Surgical Benefit in Triple-Negative Breast Cancer Patients With
    Wang Z; Wang H; Sun X; Fang Y; Lu SS; Ding SN; Chen XS; Shen KW
    Front Oncol; 2020; 10():14. PubMed ID: 32038988
    [No Abstract]   [Full Text] [Related]  

  • 12. A novel prognostic two-gene signature for triple negative breast cancer.
    Alsaleem MA; Ball G; Toss MS; Raafat S; Aleskandarany M; Joseph C; Ogden A; Bhattarai S; Rida PCG; Khani F; Davis M; Elemento O; Aneja R; Ellis IO; Green A; Mongan NP; Rakha E
    Mod Pathol; 2020 Nov; 33(11):2208-2220. PubMed ID: 32404959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature with Predictive and Prognostic Value.
    Jiang YZ; Liu YR; Xu XE; Jin X; Hu X; Yu KD; Shao ZM
    Cancer Res; 2016 Apr; 76(8):2105-14. PubMed ID: 26921339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The early-stage triple-negative breast cancer landscape derives a novel prognostic signature and therapeutic target.
    Yang YS; Ren YX; Liu CL; Hao S; Xu XE; Jin X; Jiang YZ; Shao ZM
    Breast Cancer Res Treat; 2022 Jun; 193(2):319-330. PubMed ID: 35334008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a collagen signature-based nomogram for preoperatively predicting lymph node metastasis and prognosis in colorectal cancer.
    Fu M; Chen D; Luo F; Wang G; Xu S; Wang Y; Sun C; Xu X; Li A; Zhuo S; Liu S; Yan J
    Ann Transl Med; 2021 Apr; 9(8):651. PubMed ID: 33987349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer.
    Liu NQ; Stingl C; Look MP; Smid M; Braakman RB; De Marchi T; Sieuwerts AM; Span PN; Sweep FC; Linderholm BK; Mangia A; Paradiso A; Dirix LY; Van Laere SJ; Luider TM; Martens JW; Foekens JA; Umar A
    J Natl Cancer Inst; 2014 Feb; 106(2):djt376. PubMed ID: 24399849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 39-gene signature is associated with early occurrence of distant metastasis in primary lymph-node negative breast cancers.
    Xia R; Chen S; Zhang W; Chen Y; Zhu R; Deng A
    Neoplasma; 2015; 62(5):821-6. PubMed ID: 26278156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature.
    Tutt A; Wang A; Rowland C; Gillett C; Lau K; Chew K; Dai H; Kwok S; Ryder K; Shu H; Springall R; Cane P; McCallie B; Kam-Morgan L; Anderson S; Buerger H; Gray J; Bennington J; Esserman L; Hastie T; Broder S; Sninsky J; Brandt B; Waldman F
    BMC Cancer; 2008 Nov; 8():339. PubMed ID: 19025599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.
    Yu Y; Tan Y; Xie C; Hu Q; Ouyang J; Chen Y; Gu Y; Li A; Lu N; He Z; Yang Y; Chen K; Ma J; Li C; Ma M; Li X; Zhang R; Zhong H; Ou Q; Zhang Y; He Y; Li G; Wu Z; Su F; Song E; Yao H
    JAMA Netw Open; 2020 Dec; 3(12):e2028086. PubMed ID: 33289845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc.
    Cui J; Jiang H
    Medicine (Baltimore); 2019 Oct; 98(40):e17370. PubMed ID: 31577739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.